Larx Apex LP

Amendment
CIK: 0002038992·Pooled Investment Fund·DELAWARE·Filed: Oct 21, 2025
Total Offering

Indefinite

Amount Sold

$4,134,057

Investors

4

First Sale

Oct 1, 2024

Offering Details

Type
Pooled Investment Fund
Exemptions
Rule 506(b), Section 3(c), Section 3(c)(1)
Entity Type
Limited Partnership
Year Incorporated
2024
Non-Accredited Investors
No

Related Persons

NameRole
Brandon A Spruill
Related Person

Company

Larx Apex LP

53 CALLE PALMERAS

SAN JUAN, PR, 00901

786-505-8788

SEC Filing

0002038992-25-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Larx Apex LP Form D Filing — Indefinite | FilingFlow